Greil, Richard
Tedeschi, Alessandra
Moreno, Carol
Anz, Bertrand
Larratt, Loree
Simkovic, Martin
Gill, Devinder
Gribben, John G.
Flinn, Ian W.
Wang, Zhengyuan
Cheung, Leo W. K.
Nguyen, Aaron N.
Zhou, Cathy
Styles, Lori
Demirkan, Fatih
Funding for this research was provided by:
Pharmacyclics LLC, an AbbVie Company
Janssen Research and Development
Article History
Received: 15 April 2020
Accepted: 16 April 2021
First Online: 20 May 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all participants included in the study.
: RG: honoraria: AbbVie, Amgen, AstraZeneca, Novartis, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Merck, Merck Sharp & Dohme, Roche, Sandoz, and Takeda; consultancy/advisory role: AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Janssen, Merck, Merck Sharp & Dohme, Novartis, Roche, and Takeda; research funding: Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead, Merck, Merck Sharp & Dohme, Novartis, Roche, Sandoz, and Takeda; travel, accommodations, or expenses: Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead, Janssen, Merck Sharp & Dohme, Novartis, AbbVie, and Roche. AT: consulting/advisory role: AbbVie, AstraZeneca, BeiGene, Janssen, and Sunesis; speakers bureau: AbbVie and Janssen. CM: consulting/advisory role: AbbVie, AstraZeneca, Janssen, and Sunesis; research funding: AbbVie and Janssen; speakers bureau: Janssen. BA: nothing to disclose. LL: honoraria: AbbVie and Janssen. MS: honoraria: AbbVie, Gilead, Janssen-Cilag, Acerta Pharma, and Roche; consulting/advisory role: AbbVie; speakers bureau: AbbVie, Janssen-Cilag, Gilead, and Roche; travel, accommodations, or expenses: AbbVie, Gilead, Janssen-Cilag, and Roche. DG: honoraria and consulting/advisory role: Janssen-Cilag. JGG: honoraria: AbbVie, Bristol-Myers Squibb, AstraZeneca, Janssen, and Roche; consultancy/advisory role: AbbVie, Janssen, Gilead; research funding: AstraZeneca, Celgene, and Janssen. IWF: consultancy/advisory role: AbbVie, AstraZeneca, BeiGene, Genentech, Gilead, Great Point Partners, Iksuda Therapeutics, Janssen, Juno Therapeutics, Kite Pharma, MorphoSys, Nurix Therapeutics, Pharmacyclics LLC, an AbbVie Company, Roche, Seattle Genetics, Takeda, TG Therapeutics, Unum Therapeutics, Verastem, and Yingli Pharmaceuticals; research funding: AbbVie, Acerta Pharma, Agios, ArQule, AstraZeneca, BeiGene, Calithera, Celgene, Constellation, Curis, F. Hoffman-la Roche Ltd, Forma, Forty Seven, Genentech, Gilead, IGM Biosciences, Incyte, Infinity, Janssen, Juno, Karyopharm, Kite, Loxo, Merck, MorphoSys AG, Novartis, Pfizer, Pharmacyclics LLC, an AbbVie Company, Portola, Rhizen Pharmaceuticals, Roche, Seattle Genetics, Takeda, Teva, TG Therapeutics, Trillium, Triphase Research & Development Corp, Unum, and Verastem. ZW: employment: currently with Ambry Genetics; previously with Pharmacyclics LLC, an AbbVie Company; stock or other ownership: AbbVie, AnaptysBio, Bristol-Myers Squibb, and Luxvitae; travel, accommodations, or other expenses: Ambry Genetics. LWKC: employment: Pharmacyclics LLC, an AbbVie Company; stock or other ownership: AbbVie and Eli Lilly; patents, royalties, or other intellectual property: Pharmacyclics LLC, an AbbVie Company. ANN: employment: currently with SparcBio; previously with Celgene and Pharmacyclics LLC, an AbbVie Company; stock or other ownership: AbbVie, Celgene, and SparcBio; patents, royalties, or other intellectual property: Celgene; travel, accommodations, or other expenses: Celgene. CZ and LS: employment: Pharmacyclics LLC, an AbbVie Company; stock or other ownership: AbbVie. FD: consulting/advisory role: AbbVie AstraZeneca, Amgen, and Roche; research funding: AbbVie, Janssen, Pharmacyclics LLC, an AbbVie Company, and AstraZeneca; speakers bureau: AbbVie, Amgen, and Janssen; travel, accommodations, or other expenses: AbbVie, Amgen, Pfizer, and Janssen.